Want to see RANI full AI Analyst Report?
Rani Therapeutics Holdings (RANI) Income Statement
Rani Therapeutics Holdings Income Statement
Last quarter (Q2 2026), Rani Therapeutics Holdings's total revenue was $1.71M. In Q2, Rani Therapeutics Holdings's net income was $-7.39M. See Rani Therapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.63M | $ 1.03M | $ 0.00 | $ 0.00 | $ 2.72M | |
| $ 733.00K | $ 1.03M | $ -822.00K | $ 0.00 | $ 2.72M | |
| $ 39.04M | $ 54.34M | $ 65.28M | $ 63.45M | $ 54.32M | |
| Depreciation and Amortization | $ 900.00K | $ 1.03M | $ 822.00K | $ 548.00K | $ 497.00K |
| $ -37.16M | $ -50.52M | $ -61.98M | $ -61.66M | $ -52.08M | |
| $ -38.31M | $ -53.31M | $ -66.10M | $ -63.45M | $ -51.60M | |
| $ -2.64M | $ 23.30M | $ -1.78M | $ 177.00K | $ -1.45M | |
| $ -40.95M | $ -30.02M | $ -67.88M | $ -63.27M | $ -53.05M | |
| $ -29.67M | $ -30.02M | $ -33.97M | $ -30.59M | $ -8.33M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.45 | $ -1.05 | $ -1.33 | $ -1.28 | $ -0.42 |
| Diluted EPS | $ -0.45 | $ -1.05 | $ -1.33 | $ -1.28 | $ -0.42 |
| Weighted Average Shares Outstanding | 66.14M | 28.48M | 25.50M | 23.82M | 19.53M |
| Weighted Average Shares Outstanding (Diluted) | 66.14M | 28.48M | 25.50M | 23.82M | 19.53M |
Currency in USD
